|
 |
VivitrexThis page contains recent news articles, when available, and an overview of Vivitrex but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Vivitrex is one of the first of a new generation of medicines for alcoholism, ... Though not a cure, treatment specialists believe Vivitrex and other ... BusinessWeek Alkermes agrees to license alcoholism drug Vivitrex - Jun 25, 2005 Alkermes Inc. said it agreed to license its antialcoholism drug Vivitrex to Cephalon Inc. for $160 million and possible additional payments. ... Boston Globe Alkermes Upside Highly Dependent On Vivitrex - Sep 27, 2005 Piper Jaffray maintained an "outperform" rating on Alkermes (nasdaq: ALKS - news - people ) and said further upside for shares of the pharmaceutical firm ... Forbes Cambridge firm readies push on alcoholism drug - Sep 4, 2005 The drug, called Vivitrex, has a distinct advantage over alcoholism pills now on ... After tests showed Vivitrex coupled with counseling helps reduce heavy ... Boston Globe Can Alcoholism Be Treated? - Apr 11, 2005 Campral has been on the market in Europe for 15 years, and Vivitrex is a ... Nor are Campral and Vivitrex miracle cures. Dr. Ameisen tried both, ... BusinessWeek Alkermes Touts Alcoholism Study - May 23, 2005 Vivitrex is an injectable agent that is supposed to bind to opioid receptors ... In addition to Vivitrex, all the patients in the study received counseling. ... TheStreet.com - TheStreet.com (subscription) Alcoholism Drugs Gain Popularity - Sep 13, 2005 30 on its application to begin marketing its new drug, Vivitrex. ... Vivitrex is a reformulation of naltrexone that is administered by monthly injection at ... CBS News Cephalon Could See 2006 Sales Of $30M From Vivitrol - Dec 29, 2005 Management of Cephalon and Alkermes said they plan to launch Vivitrol (formerly Vivitrex) in the second quarter of 2006, said Kulju, "a modest pushback" ... Forbes FDA Extends PDUFA Date for VIVITREX(R) to December 30, 2005; … - Dec 30, 2005 FRAZER, Pa. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sept. 20, 2005--Cephalon, Inc. (Nasdaq: CEPH) and Alkermes, Inc. (Nasdaq: ALKS) announced today that they ... businesswire.com Alkermes Selects Cephalon As Vivitrex Partner In $480M Deal - Jun 27, 2005 By Karen Pihl-Carey. A little more than two months after filing for approval of Vivitrex, Alkermes Inc. partnered the alcohol-dependence drug with Cephalon ... BioWorld Online - BioWorld Online Naltrexone Drug Wins Initial FDA Approval - Jan 3, 2006 ..."We believe Vivitrex could become the gold standard for treatment of alcohol dependence, particularly for patients with compliance issues," CIBC World ... JoinTogether.org FDA postpones decision on Alkermes application - Sep 22, 2005 Vivitrex is a monthly injectable version of naltrexone. ... Alkermes still expects to launch Vivitrex during the first half of 2006. (Stephen Heuser) ... Boston Globe … Announces Priority Review Granted for Vivitrex -Naltrexone Long... - May 27, 2005 The Prescription Drug User Fee Act ("PDUFA") date for completion of review by the FDA of the Vivitrex NDA is September 30, 2005. Vivitrex is being developed ... RedOrbit CEPHALON/ALKERMES SIGN PACT TO DEVELOP VIVITREX. - Aug 1, 2005 Cephalon, Inc. (Nasdaq: CEPH) and Alkermes, Inc. (Nasdaq: ALKS) have entered into an agreement to develop and commercialize Vivitrex (naltrexone long-acting ... Entrepreneur FDA Extends PDUFA Date for VIVITREX(R) to December 30, 2005; … - Sep 20, 2005 FRAZER, Pa. & CAMBRIDGE, Mass. -- Cephalon, Inc. (Nasdaq: CEPH) and Alkermes, Inc. (Nasdaq: ALKS) announced today that they have received notification from ... $4.95 - Business Wire - ECNext A new push to help alcoholics stay sober - Sep 27, 2005 Vivitrex is a reformulation of naltrexone that is administered by monthly injection at a doctor's office, a potentially easier treatment option to follow ... Pay-Per-View - Newsday - ProQuest Archiver Alkermes Announces Data on Vivitrex -- Naltrexone Long-Acting... - May 16, 2005 Alkermes (Nasdaq: ALKS) today announced that four abstracts related to clinical studies in the Vivitrex(R) (naltrexone long-acting injection) development ... $4.95 - Business Wire - ECNext … SIGN PACT TO DEVELOP VIVITREX. - Biotech Business | HighBeam … - Aug 1, 2005 CEPHALON/ALKERMES SIGN PACT TO DEVELOP VIVITREX. ... find Biotech Business articles. Cephalon, Inc. (Nasdaq: CEPH) and Alkermes, Inc. (Nasdaq: ALKS) have ... Pay-Per-View - Biotech Business - HighBeam Research … Announce Agreement for the Commercialization of Vivitrex(R) for... - Jun 24, 2005 Companies to Share Profits from Future Sales of Vivitrex Equally - ... Vivitrex is an investigational drug in development by Alkermes for the treatment of ... Pay-Per-View - PR Newswire - HighBeam Research Event Brief of Q2 2006 Alkermes, Inc. Earnings Conference Call - Part... - Nov 3, 2005 My question was on inventory -- VIVITREX inventory and what exactly was the ... Everybody seems to be so focus owed VIVITREX, but you've done an awesome job ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Alkermes inks rich collaboration deal for Vivitrex - Jun 23, 2005 Cephalon has agreed to pay Alkermes $160 million up front and another $110 million on the approval of Vivitrex for alcohol dependence. ... FierceBiotech Q4 2005 Alkermes, Inc. Earnings Conference Call - Final. - May 19, 2005 Rich will then present a brief update on our progress with Vivitrex, ... Second, we are preparing for the potential launch of Vivitrex in mid calendar 2006. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Q3 2005 Alkermes, Inc. Earnings Conference Call - Final. - Feb 3, 2005 Rich will review the pipeline programs and provide an update on Risperdal Consta, and Vivitrex, as well as an overview of upcoming milestones. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Alkermes' submits application for Vivitrex injectable.(Briefly... - Apr 18, 2005 Alkermes Inc. has submitted a New Drug Application to the FDA for marketing approval of Vivitrex (naltrexone long-acting injection). ... Free with registration - Alcoholism & Drug Abuse Weekly - AccessMyLibrary.com Cephalon signs Vivitrex deal with Alkermes. - Jul 4, 2005 Cephalon has entered into an agreement with Alkermes to develop and commercialize its investigational alcohol-dependence therapy Vivitrex (naltrexone ... $4.95 - Pharma Marketletter - ECNext … Submission of New Drug Application for Vivitrex for Treatment of... - Apr 1, 2005 If approved, Vivitrex would be the first medication available for the treatment of ... "This NDA submission is a major milestone in our Vivitrex development ... $4.95 - Business Wire - ECNext A New Approach to Alcoholism - Aug 8, 2005 After injection into the body, the drug could then diffuse out over a longer period of time--a month in the case of Vivitrex, Alkermes' antidote to ... Forbes FDA delays Vivitrex' approval decision.(Food and Drug Administration)(... - Oct 10, 2005 The US Food and Drug Administration has extended the action date for its priority review of the New Drug Application for Vivitrex (naltrexone long-acting ... $4.95 - Pharma Marketletter - ECNext Alkermes' Vivitrex shows good performance.(product development)(Brief... - Apr 18, 2005 Alkermes of the USA has reported positive results from a Phase III study of its alcoholism therapy, Vivitrex (naltrexone, long-acting injection). ... $4.95 - Pharma Marketletter - ECNext Merrill Lynch Global Pharmaceutical, Biotechnology & Medical … - Jan 31, 2005 The Company's lead proprietary product candidate, Vivitrex(R) ((naltrexone) long-acting injection), is a once-a-month injection for the treatment of alcohol ... Free with registration - Business Wire - AccessMyLibrary.com Q2 2005 Cephalon, Inc. Earnings Conference Call - Final. - Aug 2, 2005 With our agreement to market Vivitrex for treating alcohol dependence we have the opportunity to ... Vivitrex is a particularly exciting opportunity for us. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Alkermes up on alcoholism drug success - Apr 7, 2005 In the study, Vivitrex (naltrexone long-acting injection) reduced the median number ... "The results of the Vivitrex study show how pharmacotherapy has the ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones Alkermes' NDA for Vivtrex accepted by the US FDA.(pharmaceutial … - Jun 6, 2005 US drugmaker Alkermes has had its New Drug Application for Vivitrex ... Vivitrex is being developed as the first long-acting medication available for the ... $4.95 - Pharma Marketletter - ECNext Event Brief of Q1 2006 Alkermes, Inc. Earnings Conference Call -... - Aug 4, 2005 Vivitrex: 1. The clinical and commercial success of Consta demonstrates in the ... s next long-acting product, Vivitrex, which is a once monthly injection ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Cephalon Nears Crucial Stage - Oct 18, 2005 He says Vivitrex could be subject to a longer-than-90-day delay. Garg cites a consultant, whom he says participated in Vivitrex clinical trials, ... TheStreet.com - TheStreet.com (subscription) Biotech battles boozing - May 28, 2005 Vivitrex, injected monthly, reduces the buzz from heavy drinking, ... "We believe Vivitrex with psycho-social therapy will be the one- two punch in ... Pay-Per-View - Boston Herald - ProQuest Archiver Alkermes：FDA授予Vivitrexæ–°è?¯ç”³è¯·ä¼˜å…ˆå®¡æ‰¹æ?ƒ - May 28, 2005 ...ã€?MarketWatch旧金山5月27日讯】周五，总部设在麻çœ?剑桥的Alkermes Inc.(ALKS)称， 美国食å“?è?¯ç‰©ç®¡ç?†å±€å·²æŽˆäºˆè¯¥å…¬å?¸Vivitrexæ–°è?¯ç”³è¯·çš„优先审批待é?‡ã€‚ ... 新浪网 Alkermes Set To Grab Street's Attention In 2006 - Dec 7, 2005 ..."As we see it, the hook to the story is Vivitrex...We believe the ultimate sales potential and profitability of Vivitrex are not well understood because the ... Forbes Q3 2005 Alkermes, Inc. Earnings Conference Call - Part 2. - Feb 3, 2005 So, there should be a fair amount of discussion about--about Vivitrex looking ahead. With respect to LAR, I'm not sure what they've disclosed publicly on ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Institute backs medication to treat alcoholism.(National Institute on... - Jul 22, 2005 The Alkermes drug, Vivitrex, is a reformulation of an existing drug called ... A study released earlier this year showed that patients using Vivitrex were ... Free with registration - Boston Globe - AccessMyLibrary.com GLAXOSMITHKLINE FILES ROTARIX APPLICATION FOR FDA … - Aug 1, 2007 Article: CEPHALON/ALKERMES SIGN PACT TO DEVELOP VIVITREX. ... Vivitrex is an investigational drug ... record net sales from Vivitrex in the United States. ... Pay-Per-View - Biotech Business - HighBeam Research Article: DUSKA THERAPEUTICS PLANS NDA 505(B)(2) FILING FOR … - Jun 1, 2008 Article: CEPHALON/ALKERMES SIGN PACT TO DEVELOP VIVITREX. ... Vivitrex is an investigational drug ... record net sales from Vivitrex in the United States. ... Pay-Per-View - Biotech Business - HighBeam Research Alkermes Reports First Quarter Fiscal 2006 Financial Results;... - Aug 4, 2005 Risperdal Consta(R) sales continued to grow, we entered into a collaboration for Vivitrex that provides us with the commercial capabilities required for a ... $4.95 - Business Wire - ECNext Drug stocks fall; Alkermes sinks on FDA delay - MarketWatch - Sep 21, 2005 The drug-delivery developer said it's been told by the Food and Drug Administration that the agency has moved its action date for ruling on Vivitrex, ... MarketWatch Cephalon Investor Analyst Day - Part 1. - Dec 19, 2005 One thing we're not going to do today is talk a lot about Vivitrex. Vivitrex is Aphramese (ph) project. Aphramese will have their time to talk about their ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Cephalon Investor Analyst Day - Final. - Dec 19, 2005 One thing we're not going to do today is talk a lot about Vivitrex. Vivitrex is Aphramese (ph) project. Aphramese will have their time to talk about their ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Tablett võõrutab viinaihast - Jan 23, 2007 Uuringu tulemusel suutis Vivitrex koos kord kuus läbi viidud teraapiaga vähendada ... Seda muidugi juhul, kui Vivitrex ka tegelikult lubatud viisil toimib. ... Äripäev Online (logi sisse) First-in-class for rheumatoid arthritis.(Bristol-Mayers Squibb, Alza... - May 2, 2005 Vivitrex is a depot formulation of the opioid antagonist naltrexone. ... If it is approved, Vivitrex would be the first medication available for the ... Free with registration - Drug Topics - AccessMyLibrary.com Article: Alcoholics Getting Help From New Drugs - AP Online |... - Sep 14, 2005 30 on its application to begin marketing its new drug, Vivitrex, ... Vivitrex is a reformulation of naltrexone that is administered by monthly injection at ... Pay-Per-View - AP Online - HighBeam Research Cephalon Reports Continued Strong Growth in Second Quarter. - Aug 2, 2005 The addition of TREANDA, TRISENOX, and VIVITREX to a pipeline that already includes ATTENACE for ADHD, NUVIGIL(TM) for wakefulness, ORAVESCENT(R) fentanyl ... $4.95 - PR Newswire - ECNext Mixed Outlook for Cephalon | Robert Steyer News | Print Financial & … - Nov 1, 2005 The third drug is Vivitrex, a treatment for alcoholism that Cephalon is marketing with the drug's developer Alkermes (ALKS Quote). ... TheStreet.com - TheStreet.com (subscription) ç§‘å ±ç¶²-ç§‘æŠ€æ—¥å ±-æ–‡ç« å…§å®¹ - Apr 19, 2005 ...å?¦ä¸€ç¨®æˆ’é…’è—¥Vivitrex也將在今年晚些時候é€?交FDA審查。ä¸?é?Žï¼Œé€™å…©ç¨®å…¶å¯¦å¹¶ä¸?是新藥， 阿å?Žé…¸å·²ç¶“在æ?洲銷售了15年，而Vivitrex是1994å¹´ç?²å¾—批準的ç´?曲酮（Naltrexone） ... 科技日报 Alkermes to file first 'homegrown' product - Feb 8, 2005 Vivitrex is due to be filed in the US in the first half of this year and, ... Vivitrex could be of particular use in people with severe alcoholism, ... In-PharmaTechnologist.com Utility, strikers union go to bargaining table today - May 28, 2005 Alkermes said it plans to develop Vivitrex as a long-acting treatment administered ... Vivitrex, a generic version of naltrexone, uses Alkermes' proprietary ... Boston Globe New drugs trying to carve out niche as treatments for alcoholism |... - Sep 20, 2005 30 on its application to begin marketing its new drug, Vivitrex, ... Vivitrex is a reformulation of naltrexone that is administered by monthly injection at ... Pay-Per-View - AP Worldstream - HighBeam Research Drug shown to cut heavy drinking - Apr 20, 2005 Taken monthly, the drug Vivitrex is long-acting formulation of naltrexone, ... If approved, Vivitrex will join the already available drugs to treat ... $2.95 - Oak Ridger - NewsBank Article: Alcoholics Getting Help From New Drugs - AP Online |... - Sep 13, 2005 30 on its application to begin marketing its new drug, Vivitrex, ... Vivitrex is a reformulation of naltrexone that is administered by monthly injection at ... Pay-Per-View - AP Online - HighBeam Research Promising medications lend hope to addicts seeking treatment. - Aug 8, 2005 An injectable form of naltrexone, Vivitrex, is currently undergoing review by the FDA as a ... Vivitrex could make it easier to stay on the medication. ... Free with registration - St. Louis Post-Dispatch - AccessMyLibrary.com 解放日报报业集团网站 - Aug 11, 2006 ...还有些其他的好东西，比如一ç§?å?«å?šVivitrex一次性戒除酒瘾的针剂———或许未æ?¥è¿˜ä¼šæœ‰ 一次性戒除烟瘾，甚至毒瘾的è?¯ç‰©ã€‚ 好å?§ï¼Œä½ çƒçˆ±ç?¡çœ ，也没有任何ä¸?良嗜好，那么快速 ... 解放牛网 - 解放牛网 BARRIER RETAINS WORLDWIDE RIGHTS TO HYPHANOX. | Article from … - Nov 1, 2005 Article: CEPHALON/ALKERMES SIGN PACT TO DEVELOP VIVITREX. ... Vivitrex is an investigational drug ... record net sales from Vivitrex in the United States. ... Pay-Per-View - Biotech Business - HighBeam Research Medications help break the bonds of addiction - Jul 31, 2005 An injectable form of naltrexone, Vivitrex, is currently undergoing review by the FDA as a ... Vivitrex could make it easier to stay on the medication. ... Pay-Per-View - St. Louis Post-Dispatch - Factiva, from Dow Jones HIV home test kits ruled out - May 25, 2005 An injection of Vivitrex, developed by Alkermes, is reported to reduce heavy drinking. ... Alkemes says a recent study showed that injection of Vivitrex was ... ITWeb Alcohol dependence drug shows financial promise - May 30, 2007 Securities and Exchange Commission regarding the accounting for the Vivitrol, previously Vivitrex, collaboration with Cephalon, which markets the drug. ... In-PharmaTechnologist.com The good, the bad and the ugly - May 26, 2005 Findings from the study showed that Vivitrex(R) and counseling led to a sustained reduction in heavy drinking over an 18-month treatment period among ... honeycombconnect.com Injectable naltrexone may be effective in reducing heavy drinking.( … - May 1, 2005 Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Pettinati HM, Silverman BL, Loewy JW, Ehrich EW; Vivitrex Study Group. Efficacy and tolerability of ... Free with registration - Brown University Digest of Addiction... - AccessMyLibrary.com Long-acting injectable naltrexone reduces heavy drinking.(Patient- … - Jul 1, 2005 Garbutt JC, Kranzter HR, O'Malley SS, et al, for the Vivitrex Study Group. Efficacy and tolerability of long-acting injectable naltrexone for alcohol ... Free with registration - JAAPA-Journal of the American Academy... - AccessMyLibrary.com Alkermes (ALKS) SqueezeTrigger Price Is $13.47. Short Sellers Down … - Nov 4, 2005 Its product candidate under development, Vivitrex, is a once-a-month injection for the treatment of alcohol and opioid dependence. ... Free with registration - M2 Presswire - AccessMyLibrary.com BUSINESS BRIEFS.(TO THE POINT) - May 31, 2005 The drug maker jumped 7.5% to 11.58 after the FDA approved its application for its Vivitrex alcohol dependence medication and granted it priority review. ... Free with registration - Investor's Business Daily - AccessMyLibrary.com Injectable naltrexone shown effective in reducing heavy drinking. - Apr 11, 2005 In addition, 6.7 percent of the placebo group dropped out due to side effects as well. For more information, visit www.Alkermes.com/products/vivitrex, ... Free with registration - Alcoholism & Drug Abuse Weekly - AccessMyLibrary.com Alcoholism Drug Moves Ahead: A Promising Treatment to Be Marketed By … - Jan 4, 2006 The drug, Vivitrol, formerly called Vivitrex, is made by a Cambridge, Mass., biotechnology company, Alkermes Inc. In June, Cephalon announced it would ... RedOrbit Alkoholismus: Spritze gegen den Bierdurst - Oct 17, 2005 Und ein weiteres Präparat, Vivitrex, könnte bis Ende des Jahres zugelassen ... Das Mittel Vivitrex könnte noch vor Jahresende auf den US-Markt kommen. ... STERN.DE Ahora hay más delincuencia que hace un año Esperanza para los … - Jun 26, 2005 Se supone que una inyección de Vivitrex reduce dramáticamente la dependencia del alcohol; se obtienen mejores resultados con la ayuda del sicólogo. ... La Jornada - La Jornada (México) Alkermes' Vivitrol Cleared For Alcoholism Treatment - Apr 17, 2006 Formerly known as Vivitrex, the drug will be offered as a single-dose, 380-mg intramuscular injection that provides medication over a month. ... BioWorld Online - BioWorld Online Factiva Search - Apr 4, 2005 ALKERMES' ALCOHOL DEPENDENCE DRUG VIVITREX ON FILE WITH FDA. 04 April, 2005 BIOWORLD Today. Lorenzo, Aaron. Byline: Aaron Lorenzo, Washington Editor ... Pay-Per-View - BIOWORLD Today - Factiva, from Dow Jones Finance; Pharmaceutical firm reports loss of $0.10 per share - Mar 14, 2005 We are advancing our diabetes product candidates, are on track to file the New Drug Application for Vivitrex with the FDA in the first half of calendar 2005 ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Alkermes: NDA for alcoholism drug.(Pharmaceutical industry)(New Drug ... - Apr 11, 2005 The USA's Alkermes has submitted a New Drug Application to the US Food and Drug Administration for marketing approval of Vivitrex (haltrexone), ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Article: Drug therapy for Alcohol dependence.(PRACTICAL … - Jul 1, 2008 If approved, Vivitrex ... available for the treatment of alcohol dependence in a formulation that is ... and 2001-2002. Drug and Alcohol Dependence 2004; ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research Pfizer decline highlights mixed day for drug stocks - MarketWatch - May 27, 2005 The biotechnology group said the FDA has awarded its market application for the alcoholism treatment Vivitrex priority review status, meaning the agency ... MarketWatch Alkermes (ALKS) SqueezeTrigger Price Is $14.10. Short Sellers Are … - Jan 9, 2006 Its product candidate under development, Vivitrex, is a once-a-month injection for the treatment of alcohol and opioid dependence. ... Free with registration - M2 Presswire - AccessMyLibrary.com $68 Million in Army Parts Shipments Unaccounted For - Dec 29, 2005 The drug, called Vivitrex, is an injectable form of naltrexone administered monthly to help ward off a craving for alcohol and should be available in the ... Washington Post Vivitrol gains FDA approvable letter.(Food and Drug Administration)(Br... - Jan 9, 2006 The companies submitted the New Drug Application for Vivitrol, formerly known as Vivitrex, last spring (Marketletter April 11, 2005). ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Cephalon Could Have A Tough Year In 2007 - Dec 8, 2005 ..."The stock has moved higher on the prospects for Sparlon and Vivitrex," he said. "Now we need approvals for both products to take the stock to a new range." ... Forbes Alkermes outperform - Sep 27, 2005 Angesichts der erfolgreichen Markteinführung von "Campral" würden die Analysten ihre Umsatzprognose für das Medikament "Vivitrex" nach oben korrigieren. ... FINANZEN.NET NEWS - FINANZEN.NET NEWS Avon Falls on Lowered Guidance - Sep 21, 2005 30, for priority review of their New Drug Application for Vivitrex, an alcoholism treatment. Qualcomm (QCOM ) raised its fourth quarter earnings per share ... BusinessWeek Alkermes auf jeden Fall halten - Nov 3, 2005 Vivitrex solle zur Behandlung von Alkohol-Sucht eingesetzt werden. Die Alkermes-Aktie hätten die Experten bereits im April dieses Jahres zu einem Kurs in ... AktienCheck Alkermes/Chephalon: FDA läßt auf sich warten - Sep 21, 2005 Dezember über die Zulassung von „Vivitrexâ€? entscheiden will. Zuvor war der Beschluss für den ... Vivitrex wurde zur Behandlung von Alkoholismus entwickelt. ... FinanzNachrichten.de Alkermes: Erfolg bei Alkohol-Studie - Apr 5, 2005 Eine Studie der University of North Carolina hat ergeben, dass die Injektion von Vivitrex das Bedürfnis starker Trinker nach Alkohol deutlich lindern kann. ... FinanzNachrichten.de Alkermes slashes revenue forecast 30% - Feb 4, 2005 The Cambridge company said it adjusted the forecast based on expected manufacturing revenue and the timing of a partnership related to its Vivitrex drug, ... Boston Globe Highlights of rising and falling US stocks - MarketWatch - Apr 6, 2005 Alkermes' shares leapt more than 8% after the company said a Phase III clinical trial of Vivitrex has shown positive results in the treatment of heavy ... MarketWatch National Briefing - Apr 6, 2005 Mass., that recently filed for government approval to market the injection preparation, Vivitrex. Researchers at the University of North Carolina said ... New York Times Drug shares close lower after Nitromed decision - MarketWatch - Jun 24, 2005 Alkermes (NASDAQ:ALKS) announced that it was partnering with Cephalon (NASDAQ:CEPH) to market an alcoholism drug, Vivitrex, which is awaiting FDA approval. ... MarketWatch Fighting Alcoholism With a Pill - Aug 23, 2005 Vivitrex, made by the biotech company Alkermes Inc., is a monthly injection of naltrexone. Researchers believe the long-acting form will be more effective, ... Wall Street Journal BellwetherReport.com is Tracking Alkermes Inc. - May 25, 2006 Alkermes' own drug pipeline includes Vivitrex, a potential drug therapy for alcohol addiction. Shares were up 6% following the announcement of the Company's ... $4.95 - M2 Presswire - ECNext Operating profit triples for Boston Medical Center - May 24, 2005 That study showed the monthly injection of the drug Vivitrex was effective in helping alcoholics stop craving drink. (Reuters) ... Boston Globe WASHINGTON IN BRIEF | Article from The Washington Post | HighBeam … - Dec 29, 2005 The drug, called Vivitrex, is an injectable form of naltrexone administered monthly to help ward off a craving for alcohol and should be available in the ... Pay-Per-View - Washington Post - HighBeam Research Article: 40 drugs with buzz: Matthew Arnold looks at 40 of the most … - Oct 1, 2006 ..."The data from this Phase III trial with Vivitrex indicates a potentially significant ... improve outcomes for alcohol-dependent patients. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Business News in Brief - Sep 7, 2005 The others are: Attenace for attention deficit hyperactivity disorder; Nuvigil for excessive sleepiness; Vivitrex, a long-acting injection of naltrexone to ... $2.95 - Philadelphia Inquirer - NewsBank US Stock-Index Futures Rise; Merck, GM Shares Gain in Europe - Apr 6, 2005 The company's Vivitrex, given in a monthly injection, reduced male binge drinking by 44 percent, according to a company-funded study in the April 6 Journal ... Bloomberg The People's Pharmacy - Mar 6, 2005 A long-acting injectable form called Vivitrex is undergoing study. Naltrexone may cause nausea, fatigue and headache. The Food and Drug Administration ... Seattle Times Big biotech embraces direct-to-consumer advertising - Sep 30, 2005 Despite the fact that Alkermes' Vivitrex, a once-monthly injectible treatment for alcohol addiction, currently under review for FDA approval, ... Nature.com |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |